Two Novel PKLR Variants in Pyruvate Kinase Deficiency: Insights From Clinical, Molecular and Functional Analysis
International Journal of Laboratory Hematology · 2026-08 · 48 (4) · 866-874
DOI: 10.1111/ijlh.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 28.04.2026. Verfasst von Huaxia Xiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Congenital Nonspherocytic, Mutation, Pyruvate Kinase, Pyruvate Metabolism, Inborn Errors. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Pyruvate kinase deficiency (PKD) is a rare cause of hereditary non‐spherocytic hemolytic anemia. This study reports the clinical and molecular characterization of three pediatric PKD cases, focusing on two novel PKLR variants.
Methods
Clinical and laboratory data were reviewed. PKLR gene was analyzed by next‐generation sequencing and validated by Sanger sequencing. Pathogenicity was predicted using in silico tools and ACMG criteria. Structural consequences were modeled with AlphaFold3 and Chimera‐X. Functional impact was assessed by Western blot and immunofluorescence in transfected 293T cells.
Results
All patients presented with neonatal hemolytic anemia. Genetic analysis revealed compound heterozygosity for PKLR mutations. Two novel variants were identified: c.1708G>A (p.Val570Met) and c.1430C>T (p.Thr477Ile). In silico analysis predicted both as damaging. Structural modeling suggested p.Val570Met disrupts inter‐subunit hydrogen bonds, while p.Thr477Ile lies within the fructose‐1,6‐bisphosphate (FBP) binding loop. In vitro, both mutants showed reduced protein expression compared to wild‐type but normal cytoplasmic localization.
Conclusion
We identified two novel PKLR variants expanding the mutational spectrum of PKD. Integrated analysis suggests p.Val570Met may impair tetramer stability, whereas p.Thr477Ile likely affects allosteric regulation. These findings underscore the value of combining clinical phenotyping with functional studies for accurate variant interpretation in PKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- Department of Pediatrics, The Affiliated Hospital of Guilin Medical College, Guilin, Guangxi, China.
- State Key Laboratory of Targeting Oncology, Guangxi Medical University, Nanning, Guangxi, China.
ORCID-Profile: Huaxia Xiang, Mengxin Yang, Zhihao Lin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xiang, H., Wen, Y., Yang, M., Jiang, J., Li, Y., He, C., Lin, Z., & Wei, H. (2026). Two Novel PKLR Variants in Pyruvate Kinase Deficiency: Insights From Clinical, Molecular and Functional Analysis. International Journal of Laboratory Hematology, 48(4), 866-874. https://doi.org/10.1111/ijlh.70125
Vancouver
Xiang H, Wen Y, Yang M, Jiang J, Li Y, He C, et al. Two Novel PKLR Variants in Pyruvate Kinase Deficiency: Insights From Clinical, Molecular and Functional Analysis. International Journal of Laboratory Hematology. 2026;48(4):866-874. doi:10.1111/ijlh.70125
BibTeX
@article{Xiang2026,
author = {Xiang, Huaxia and Wen, Yuxiu and Yang, Mengxin and Jiang, Jiali and Li, Yuping and He, Changjin and Lin, Zhihao and Wei, Hongying},
title = {Two Novel PKLR Variants in Pyruvate Kinase Deficiency: Insights From Clinical, Molecular and Functional Analysis},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {4},
pages = {866--874},
doi = {10.1111/ijlh.70125}
}
EUVIMED